[
  {
    "objectID": "quarto/index.html",
    "href": "quarto/index.html",
    "title": "Impact of Iron Deficiency Anemia on Inpatient Outcomes in Inflammatory Bowel Disease",
    "section": "",
    "text": "Reference Studies:\n\nSaad et al., 2026\nAlharbi et al., 2024\n\nStudy Objective:\nTo investigate the clinical and economic impact of Iron Deficiency Anemia (IDA) in patients hospitalized with Inflammatory Bowel Disease (IBD). Specifically, this study evaluates whether comorbid IDA is independently associated with higher in-hospital mortality, increased healthcare utilization (length of stay, inflation-adjusted costs), need for inpatient blood transfusions, and adverse discharge disposition.\nData Source:\nA retrospective cohort study of the 2017–2022 Nationwide Inpatient Sample (NIS), developed by the Healthcare Cost and Utilization Project (HCUP). The NIS is the largest publicly available all-payer inpatient database in the United States, representing a 20% stratified sample of discharges from U.S. community hospitals and enabling generation of national estimates through survey-weighted analyses.\nCohort Definition:\nIndex hospitalizations were included if they met all of the following criteria:\n\nAdults aged ≥18 years\nDiagnosis of Inflammatory Bowel Disease (Crohn’s Disease or Ulcerative Colitis), identified using ICD-10-CM codes K50.x and K51.x\n\nExposure Categories:\nIron Deficiency Anemia (IDA) status, identified using ICD-10-CM codes D50.x:\n\nIBD without IDA: Absence of IDA diagnosis codes (reference group)\nIBD with IDA: Presence of IDA (D50.x)\n\nOutcomes of Interest:\n\nPrimary Outcomes:\n\nIn-hospital mortality\nInpatient blood transfusion\n\nSecondary Outcomes:\n\nLength of stay (LOS, days)\nInflation-adjusted total hospital costs (U.S. dollars, adjusted to 2022 using CPI)\nNon-home discharge (transfer to skilled nursing facility, long-term care, hospice, or in-hospital death)\n\n\nCovariates and Variable Construction:\n\nDemographic & Socioeconomic Factors:\n\nAge (continuous, years)\nSex (Male/Female)\nRace/ethnicity (White, Black, Hispanic, Asian or Pacific Islander, Other)\nPrimary expected payer (Medicare, Medicaid, Private, Other)\nZIP-based median household income quartile (Q1–Q4)\n\nHospital Characteristics:\n\nHospital region (Northeast, Midwest, South, West)\nBed size (Small, Medium, Large)\nLocation and teaching status (Rural, Urban non-teaching, Urban teaching)\n\nClinical Characteristics:\n\nAdmission type (Elective vs. Non-elective)\nIBD Phenotype (Crohn’s Disease vs. Ulcerative Colitis)\nElixhauser Comorbidity Index (continuous sum score)\nSelected baseline confounders: Clostridioides difficile infection, liver disease, renal failure, diabetes mellitus, hypertension, obesity\n\n\nStatistical Methods:\n\nSurvey Design and Weighting:\n\nAnalyses incorporated NIS’s complex sampling design using discharge weights (DISCWT), strata (NIS_STRATUM), and clustering (HOSP_NIS). The survey package in R was used to generate nationally representative estimates.\n\nDescriptive Statistics:\n\nBaseline characteristics and outcomes were summarized by IDA status (IBD without IDA vs. IBD with IDA).\nDesign-based statistical tests: Rao–Scott adjusted chi-square test for categorical variables; design-based t-test/Wilcoxon for continuous variables.\n\nMultivariable Regression:\n\nBinary outcomes:\n\nSurvey-weighted logistic regression with quasibinomial family\nAdjusted odds ratios (aORs) with 95% confidence intervals\n\nContinuous outcomes:\n\nSurvey-weighted linear regression with gaussian family\nAdjusted beta coefficients (β) with 95% confidence intervals\n\nAdjustment variables: Age, sex, race/ethnicity, primary payer, income quartile, hospital region, bed size, teaching status, admission type (elective vs. non-elective), IBD phenotype (Crohn’s Disease vs. Ulcerative Colitis), and the Elixhauser Comorbidity Index sum score.\nReference group: IBD without IDA\n\n\nSoftware:\nAll analyses were conducted in R Statistical Language (Version 4.5.1; R Foundation for Statistical Computing, Vienna, Austria)."
  },
  {
    "objectID": "quarto/index.html#preamble",
    "href": "quarto/index.html#preamble",
    "title": "Impact of Iron Deficiency Anemia on Inpatient Outcomes in Inflammatory Bowel Disease",
    "section": "",
    "text": "Reference Studies:\n\nSaad et al., 2026\nAlharbi et al., 2024\n\nStudy Objective:\nTo investigate the clinical and economic impact of Iron Deficiency Anemia (IDA) in patients hospitalized with Inflammatory Bowel Disease (IBD). Specifically, this study evaluates whether comorbid IDA is independently associated with higher in-hospital mortality, increased healthcare utilization (length of stay, inflation-adjusted costs), need for inpatient blood transfusions, and adverse discharge disposition.\nData Source:\nA retrospective cohort study of the 2017–2022 Nationwide Inpatient Sample (NIS), developed by the Healthcare Cost and Utilization Project (HCUP). The NIS is the largest publicly available all-payer inpatient database in the United States, representing a 20% stratified sample of discharges from U.S. community hospitals and enabling generation of national estimates through survey-weighted analyses.\nCohort Definition:\nIndex hospitalizations were included if they met all of the following criteria:\n\nAdults aged ≥18 years\nDiagnosis of Inflammatory Bowel Disease (Crohn’s Disease or Ulcerative Colitis), identified using ICD-10-CM codes K50.x and K51.x\n\nExposure Categories:\nIron Deficiency Anemia (IDA) status, identified using ICD-10-CM codes D50.x:\n\nIBD without IDA: Absence of IDA diagnosis codes (reference group)\nIBD with IDA: Presence of IDA (D50.x)\n\nOutcomes of Interest:\n\nPrimary Outcomes:\n\nIn-hospital mortality\nInpatient blood transfusion\n\nSecondary Outcomes:\n\nLength of stay (LOS, days)\nInflation-adjusted total hospital costs (U.S. dollars, adjusted to 2022 using CPI)\nNon-home discharge (transfer to skilled nursing facility, long-term care, hospice, or in-hospital death)\n\n\nCovariates and Variable Construction:\n\nDemographic & Socioeconomic Factors:\n\nAge (continuous, years)\nSex (Male/Female)\nRace/ethnicity (White, Black, Hispanic, Asian or Pacific Islander, Other)\nPrimary expected payer (Medicare, Medicaid, Private, Other)\nZIP-based median household income quartile (Q1–Q4)\n\nHospital Characteristics:\n\nHospital region (Northeast, Midwest, South, West)\nBed size (Small, Medium, Large)\nLocation and teaching status (Rural, Urban non-teaching, Urban teaching)\n\nClinical Characteristics:\n\nAdmission type (Elective vs. Non-elective)\nIBD Phenotype (Crohn’s Disease vs. Ulcerative Colitis)\nElixhauser Comorbidity Index (continuous sum score)\nSelected baseline confounders: Clostridioides difficile infection, liver disease, renal failure, diabetes mellitus, hypertension, obesity\n\n\nStatistical Methods:\n\nSurvey Design and Weighting:\n\nAnalyses incorporated NIS’s complex sampling design using discharge weights (DISCWT), strata (NIS_STRATUM), and clustering (HOSP_NIS). The survey package in R was used to generate nationally representative estimates.\n\nDescriptive Statistics:\n\nBaseline characteristics and outcomes were summarized by IDA status (IBD without IDA vs. IBD with IDA).\nDesign-based statistical tests: Rao–Scott adjusted chi-square test for categorical variables; design-based t-test/Wilcoxon for continuous variables.\n\nMultivariable Regression:\n\nBinary outcomes:\n\nSurvey-weighted logistic regression with quasibinomial family\nAdjusted odds ratios (aORs) with 95% confidence intervals\n\nContinuous outcomes:\n\nSurvey-weighted linear regression with gaussian family\nAdjusted beta coefficients (β) with 95% confidence intervals\n\nAdjustment variables: Age, sex, race/ethnicity, primary payer, income quartile, hospital region, bed size, teaching status, admission type (elective vs. non-elective), IBD phenotype (Crohn’s Disease vs. Ulcerative Colitis), and the Elixhauser Comorbidity Index sum score.\nReference group: IBD without IDA\n\n\nSoftware:\nAll analyses were conducted in R Statistical Language (Version 4.5.1; R Foundation for Statistical Computing, Vienna, Austria)."
  },
  {
    "objectID": "quarto/index.html#baseline-characteristics-table",
    "href": "quarto/index.html#baseline-characteristics-table",
    "title": "Impact of Iron Deficiency Anemia on Inpatient Outcomes in Inflammatory Bowel Disease",
    "section": "Baseline Characteristics Table:",
    "text": "Baseline Characteristics Table:\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nOverall\nN = 521,9751\nIBD without IDA\nN = 445,1401\nIBD with IDA\nN = 76,8351\np-value2\n\n\n\n\nAge, years\n46 (18)\n47 (18)\n42 (18)\n&lt;0.001\n\n\nFemale Sex\n\n\n\n\n\n\n&lt;0.001\n\n\n    Male\n241,725 (46%)\n207,515 (47%)\n34,210 (45%)\n\n\n\n\n    Female\n280,200 (54%)\n237,590 (53%)\n42,610 (55%)\n\n\n\n\nRace/Ethnicity\n\n\n\n\n\n\n&lt;0.001\n\n\n    White\n370,490 (73%)\n323,700 (74%)\n46,790 (62%)\n\n\n\n\n    Asian or Pacific Islander\n7,960 (1.6%)\n6,435 (1.5%)\n1,525 (2.0%)\n\n\n\n\n    Black\n71,685 (14%)\n56,015 (13%)\n15,670 (21%)\n\n\n\n\n    Hispanic\n43,535 (8.5%)\n35,210 (8.1%)\n8,325 (11%)\n\n\n\n\n    Other\n15,830 (3.1%)\n13,230 (3.0%)\n2,600 (3.5%)\n\n\n\n\nMedian Household Income Quartile (by ZIP)\n\n\n\n\n\n\n&lt;0.001\n\n\n    Q1\n129,875 (25%)\n109,625 (25%)\n20,250 (27%)\n\n\n\n\n    Q2\n130,780 (25%)\n111,750 (25%)\n19,030 (25%)\n\n\n\n\n    Q3\n132,230 (26%)\n113,295 (26%)\n18,935 (25%)\n\n\n\n\n    Q4\n122,160 (24%)\n104,555 (24%)\n17,605 (23%)\n\n\n\n\nPrimary Expected Payer\n\n\n\n\n\n\n&lt;0.001\n\n\n    Medicare\n139,090 (27%)\n123,185 (28%)\n15,905 (21%)\n\n\n\n\n    Medicaid\n97,575 (19%)\n78,995 (18%)\n18,580 (24%)\n\n\n\n\n    Other\n45,315 (8.7%)\n37,570 (8.5%)\n7,745 (10%)\n\n\n\n\n    Private\n239,220 (46%)\n204,705 (46%)\n34,515 (45%)\n\n\n\n\nHospital Region\n\n\n\n\n\n\n&lt;0.001\n\n\n    Northeast\n108,465 (21%)\n93,590 (21%)\n14,875 (19%)\n\n\n\n\n    Midwest\n125,755 (24%)\n106,570 (24%)\n19,185 (25%)\n\n\n\n\n    South\n199,475 (38%)\n171,070 (38%)\n28,405 (37%)\n\n\n\n\n    West\n88,280 (17%)\n73,910 (17%)\n14,370 (19%)\n\n\n\n\nHospital Bed Size\n\n\n\n\n\n\n&lt;0.001\n\n\n    Large\n270,680 (52%)\n228,825 (51%)\n41,855 (54%)\n\n\n\n\n    Medium\n142,815 (27%)\n122,745 (28%)\n20,070 (26%)\n\n\n\n\n    Small\n108,480 (21%)\n93,570 (21%)\n14,910 (19%)\n\n\n\n\nHospital Location & Teaching Status\n\n\n\n\n\n\n&lt;0.001\n\n\n    Urban, teaching\n400,325 (77%)\n338,035 (76%)\n62,290 (81%)\n\n\n\n\n    Rural\n33,505 (6.4%)\n30,110 (6.8%)\n3,395 (4.4%)\n\n\n\n\n    Urban, non-teaching\n88,145 (17%)\n76,995 (17%)\n11,150 (15%)\n\n\n\n\nElective Admission\n\n\n\n\n\n\n&lt;0.001\n\n\n    Non-elective\n447,220 (86%)\n377,190 (85%)\n70,030 (91%)\n\n\n\n\n    Elective\n74,315 (14%)\n67,605 (15%)\n6,710 (8.7%)\n\n\n\n\nElixhauser Comorbidity Index\n2.20 (1.84)\n2.05 (1.81)\n3.10 (1.75)\n&lt;0.001\n\n\nIBD Phenotype\n\n\n\n\n\n\n&lt;0.001\n\n\n    Crohn's Disease\n319,885 (61%)\n277,890 (62%)\n41,995 (55%)\n\n\n\n\n    Ulcerative Colitis\n202,090 (39%)\n167,250 (38%)\n34,840 (45%)\n\n\n\n\nClostridioides difficile Infection\n12,775 (2.4%)\n9,960 (2.2%)\n2,815 (3.7%)\n&lt;0.001\n\n\nLiver Disease\n29,030 (5.6%)\n24,925 (5.6%)\n4,105 (5.3%)\n0.2\n\n\nRenal Failure\n30,480 (5.8%)\n26,575 (6.0%)\n3,905 (5.1%)\n&lt;0.001\n\n\nDiabetes Mellitus\n53,815 (10%)\n47,360 (11%)\n6,455 (8.4%)\n&lt;0.001\n\n\nHypertension\n159,540 (31%)\n141,365 (32%)\n18,175 (24%)\n&lt;0.001\n\n\nObesity\n55,980 (11%)\n48,395 (11%)\n7,585 (9.9%)\n&lt;0.001\n\n\n\n1 Mean (SD); n (%)\n\n\n2 Design-based KruskalWallis test; Pearson’s X^2: Rao & Scott adjustment"
  },
  {
    "objectID": "quarto/index.html#outcomes-table-univariable-analysis",
    "href": "quarto/index.html#outcomes-table-univariable-analysis",
    "title": "Impact of Iron Deficiency Anemia on Inpatient Outcomes in Inflammatory Bowel Disease",
    "section": "Outcomes Table (Univariable Analysis):",
    "text": "Outcomes Table (Univariable Analysis):\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nOverall\nN = 521,9751\nIBD without IDA\nN = 445,1401\nIBD with IDA\nN = 76,8351\np-value2\n\n\n\n\nIn-hospital Mortality\n1,680 (0.3%)\n1,540 (0.3%)\n140 (0.2%)\n&lt;0.001\n\n\nLength of Stay (days)\n4.0 (2.0, 6.0)\n3.0 (2.0, 6.0)\n4.0 (3.0, 7.0)\n&lt;0.001\n\n\nInflation-Adjusted Hospital Costs (2022 USD)\n9,382 (5,905, 16,481)\n9,149 (5,780, 16,109)\n10,751 (6,788, 18,596)\n&lt;0.001\n\n\nNon-Home Discharge\n41,700 (8.0%)\n35,740 (8.0%)\n5,960 (7.8%)\n0.3\n\n\nInpatient Blood Transfusion\n29,340 (5.6%)\n19,750 (4.4%)\n9,590 (12%)\n&lt;0.001\n\n\n\n1 n (%); Median (Q1, Q3)\n\n\n2 Pearson’s X^2: Rao & Scott adjustment; Design-based KruskalWallis test"
  },
  {
    "objectID": "quarto/index.html#multivariable-logistic-regression-models",
    "href": "quarto/index.html#multivariable-logistic-regression-models",
    "title": "Impact of Iron Deficiency Anemia on Inpatient Outcomes in Inflammatory Bowel Disease",
    "section": "Multivariable Logistic Regression Models:",
    "text": "Multivariable Logistic Regression Models:\n\nInpatient Blood Transfusion\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nOR\n95% CI\np-value\n\n\n\n\nIDA categories\n\n\n\n\n\n\n\n\n    IBD without IDA\n—\n—\n\n\n\n\n    IBD with IDA\n2.47\n2.32, 2.64\n&lt;0.001\n\n\nIBD Phenotype\n\n\n\n\n\n\n\n\n    Crohn's Disease\n—\n—\n\n\n\n\n    Ulcerative Colitis\n1.98\n1.87, 2.10\n&lt;0.001\n\n\nAge, years\n1.00\n1.00, 1.00\n0.10\n\n\nFemale Sex\n\n\n\n\n\n\n\n\n    Male\n—\n—\n\n\n\n\n    Female\n0.89\n0.84, 0.94\n&lt;0.001\n\n\nRace/Ethnicity\n\n\n\n\n\n\n\n\n    White\n—\n—\n\n\n\n\n    Asian or Pacific Islander\n1.65\n1.38, 1.97\n&lt;0.001\n\n\n    Black\n1.44\n1.32, 1.56\n&lt;0.001\n\n\n    Hispanic\n1.30\n1.18, 1.43\n&lt;0.001\n\n\n    Other\n1.46\n1.26, 1.69\n&lt;0.001\n\n\nMedian Household Income Quartile (by ZIP)\n\n\n\n\n\n\n\n\n    Q1\n—\n—\n\n\n\n\n    Q2\n0.98\n0.90, 1.06\n0.5\n\n\n    Q3\n1.04\n0.95, 1.13\n0.4\n\n\n    Q4\n1.04\n0.95, 1.14\n0.3\n\n\nPrimary Expected Payer\n\n\n\n\n\n\n\n\n    Medicare\n—\n—\n\n\n\n\n    Medicaid\n1.10\n0.99, 1.21\n0.067\n\n\n    Other\n1.11\n0.99, 1.25\n0.077\n\n\n    Private\n0.99\n0.91, 1.08\n0.9\n\n\nHospital Region\n\n\n\n\n\n\n\n\n    Northeast\n—\n—\n\n\n\n\n    Midwest\n0.55\n0.49, 0.63\n&lt;0.001\n\n\n    South\n0.95\n0.87, 1.04\n0.3\n\n\n    West\n0.92\n0.82, 1.02\n0.12\n\n\nHospital Bed Size\n\n\n\n\n\n\n\n\n    Large\n—\n—\n\n\n\n\n    Medium\n1.14\n1.05, 1.24\n0.001\n\n\n    Small\n1.06\n0.97, 1.16\n0.2\n\n\nHospital Location & Teaching Status\n\n\n\n\n\n\n\n\n    Urban, teaching\n—\n—\n\n\n\n\n    Rural\n1.25\n1.10, 1.43\n&lt;0.001\n\n\n    Urban, non-teaching\n1.23\n1.13, 1.33\n&lt;0.001\n\n\nElective Admission\n\n\n\n\n\n\n\n\n    Non-elective\n—\n—\n\n\n\n\n    Elective\n1.06\n0.96, 1.17\n0.2\n\n\nElixhauser Comorbidity Index\n1.18\n1.16, 1.20\n&lt;0.001\n\n\n\nAbbreviations: CI = Confidence Interval, OR = Odds Ratio\n\n\n\n\n\n\n\n\n\n\nIn-Hospital Mortality\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nOR\n95% CI\np-value\n\n\n\n\nIDA categories\n\n\n\n\n\n\n\n\n    IBD without IDA\n—\n—\n\n\n\n\n    IBD with IDA\n0.35\n0.23, 0.54\n&lt;0.001\n\n\nIBD Phenotype\n\n\n\n\n\n\n\n\n    Crohn's Disease\n—\n—\n\n\n\n\n    Ulcerative Colitis\n1.31\n1.03, 1.66\n0.025\n\n\nAge, years\n1.05\n1.04, 1.06\n&lt;0.001\n\n\nFemale Sex\n\n\n\n\n\n\n\n\n    Male\n—\n—\n\n\n\n\n    Female\n0.78\n0.62, 0.98\n0.034\n\n\nRace/Ethnicity\n\n\n\n\n\n\n\n\n    White\n—\n—\n\n\n\n\n    Asian or Pacific Islander\n0.90\n0.33, 2.48\n0.8\n\n\n    Black\n1.08\n0.75, 1.55\n0.7\n\n\n    Hispanic\n0.66\n0.38, 1.14\n0.13\n\n\n    Other\n1.04\n0.50, 2.14\n&gt;0.9\n\n\nMedian Household Income Quartile (by ZIP)\n\n\n\n\n\n\n\n\n    Q1\n—\n—\n\n\n\n\n    Q2\n0.97\n0.71, 1.33\n0.9\n\n\n    Q3\n0.66\n0.47, 0.93\n0.016\n\n\n    Q4\n0.75\n0.53, 1.06\n0.11\n\n\nPrimary Expected Payer\n\n\n\n\n\n\n\n\n    Medicare\n—\n—\n\n\n\n\n    Medicaid\n1.66\n1.07, 2.56\n0.023\n\n\n    Other\n1.23\n0.68, 2.25\n0.5\n\n\n    Private\n0.90\n0.62, 1.32\n0.6\n\n\nHospital Region\n\n\n\n\n\n\n\n\n    Northeast\n—\n—\n\n\n\n\n    Midwest\n0.63\n0.45, 0.88\n0.007\n\n\n    South\n0.67\n0.50, 0.91\n0.011\n\n\n    West\n0.79\n0.56, 1.11\n0.2\n\n\nHospital Bed Size\n\n\n\n\n\n\n\n\n    Large\n—\n—\n\n\n\n\n    Medium\n0.95\n0.73, 1.23\n0.7\n\n\n    Small\n0.73\n0.54, 1.00\n0.047\n\n\nHospital Location & Teaching Status\n\n\n\n\n\n\n\n\n    Urban, teaching\n—\n—\n\n\n\n\n    Rural\n0.80\n0.51, 1.26\n0.3\n\n\n    Urban, non-teaching\n0.90\n0.66, 1.23\n0.5\n\n\nElective Admission\n\n\n\n\n\n\n\n\n    Non-elective\n—\n—\n\n\n\n\n    Elective\n1.49\n1.03, 2.16\n0.036\n\n\nElixhauser Comorbidity Index\n1.62\n1.55, 1.69\n&lt;0.001\n\n\n\nAbbreviations: CI = Confidence Interval, OR = Odds Ratio\n\n\n\n\n\n\n\n\n\n\nNon-Home Discharge\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nOR\n95% CI\np-value\n\n\n\n\nIDA categories\n\n\n\n\n\n\n\n\n    IBD without IDA\n—\n—\n\n\n\n\n    IBD with IDA\n0.82\n0.76, 0.88\n&lt;0.001\n\n\nIBD Phenotype\n\n\n\n\n\n\n\n\n    Crohn's Disease\n—\n—\n\n\n\n\n    Ulcerative Colitis\n1.05\n1.00, 1.11\n0.038\n\n\nAge, years\n1.01\n1.01, 1.01\n&lt;0.001\n\n\nFemale Sex\n\n\n\n\n\n\n\n\n    Male\n—\n—\n\n\n\n\n    Female\n0.79\n0.76, 0.83\n&lt;0.001\n\n\nRace/Ethnicity\n\n\n\n\n\n\n\n\n    White\n—\n—\n\n\n\n\n    Asian or Pacific Islander\n0.81\n0.65, 1.00\n0.050\n\n\n    Black\n1.16\n1.08, 1.25\n&lt;0.001\n\n\n    Hispanic\n0.82\n0.74, 0.90\n&lt;0.001\n\n\n    Other\n1.08\n0.94, 1.24\n0.3\n\n\nMedian Household Income Quartile (by ZIP)\n\n\n\n\n\n\n\n\n    Q1\n—\n—\n\n\n\n\n    Q2\n0.90\n0.85, 0.96\n0.002\n\n\n    Q3\n0.85\n0.80, 0.91\n&lt;0.001\n\n\n    Q4\n0.78\n0.72, 0.84\n&lt;0.001\n\n\nPrimary Expected Payer\n\n\n\n\n\n\n\n\n    Medicare\n—\n—\n\n\n\n\n    Medicaid\n0.99\n0.91, 1.07\n0.8\n\n\n    Other\n0.90\n0.82, 0.99\n0.037\n\n\n    Private\n0.49\n0.45, 0.53\n&lt;0.001\n\n\nHospital Region\n\n\n\n\n\n\n\n\n    Northeast\n—\n—\n\n\n\n\n    Midwest\n0.76\n0.71, 0.82\n&lt;0.001\n\n\n    South\n0.72\n0.68, 0.77\n&lt;0.001\n\n\n    West\n0.79\n0.73, 0.86\n&lt;0.001\n\n\nHospital Bed Size\n\n\n\n\n\n\n\n\n    Large\n—\n—\n\n\n\n\n    Medium\n1.16\n1.10, 1.23\n&lt;0.001\n\n\n    Small\n1.32\n1.24, 1.41\n&lt;0.001\n\n\nHospital Location & Teaching Status\n\n\n\n\n\n\n\n\n    Urban, teaching\n—\n—\n\n\n\n\n    Rural\n1.61\n1.48, 1.76\n&lt;0.001\n\n\n    Urban, non-teaching\n1.32\n1.24, 1.40\n&lt;0.001\n\n\nElective Admission\n\n\n\n\n\n\n\n\n    Non-elective\n—\n—\n\n\n\n\n    Elective\n0.47\n0.42, 0.52\n&lt;0.001\n\n\nElixhauser Comorbidity Index\n1.23\n1.22, 1.25\n&lt;0.001\n\n\n\nAbbreviations: CI = Confidence Interval, OR = Odds Ratio"
  },
  {
    "objectID": "quarto/index.html#multivariable-linear-regression-models",
    "href": "quarto/index.html#multivariable-linear-regression-models",
    "title": "Impact of Iron Deficiency Anemia on Inpatient Outcomes in Inflammatory Bowel Disease",
    "section": "Multivariable Linear Regression Models:",
    "text": "Multivariable Linear Regression Models:\n\nLength of Stay (Days)\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nBeta\n95% CI\np-value\n\n\n\n\nIDA categories\n\n\n\n\n\n\n\n\n    IBD without IDA\n—\n—\n\n\n\n\n    IBD with IDA\n0.09\n-0.03, 0.20\n0.14\n\n\nIBD Phenotype\n\n\n\n\n\n\n\n\n    Crohn's Disease\n—\n—\n\n\n\n\n    Ulcerative Colitis\n0.16\n0.09, 0.24\n&lt;0.001\n\n\nAge, years\n-0.01\n-0.01, -0.01\n&lt;0.001\n\n\nFemale Sex\n\n\n\n\n\n\n\n\n    Male\n—\n—\n\n\n\n\n    Female\n-0.22\n-0.29, -0.15\n&lt;0.001\n\n\nRace/Ethnicity\n\n\n\n\n\n\n\n\n    White\n—\n—\n\n\n\n\n    Asian or Pacific Islander\n0.30\n-0.10, 0.70\n0.14\n\n\n    Black\n-0.02\n-0.14, 0.09\n0.7\n\n\n    Hispanic\n0.00\n-0.14, 0.13\n&gt;0.9\n\n\n    Other\n0.01\n-0.18, 0.20\n&gt;0.9\n\n\nMedian Household Income Quartile (by ZIP)\n\n\n\n\n\n\n\n\n    Q1\n—\n—\n\n\n\n\n    Q2\n0.09\n0.00, 0.19\n0.063\n\n\n    Q3\n0.08\n-0.03, 0.18\n0.14\n\n\n    Q4\n0.11\n0.00, 0.21\n0.056\n\n\nPrimary Expected Payer\n\n\n\n\n\n\n\n\n    Medicare\n—\n—\n\n\n\n\n    Medicaid\n0.29\n0.15, 0.43\n&lt;0.001\n\n\n    Other\n0.12\n-0.03, 0.27\n0.12\n\n\n    Private\n0.18\n0.07, 0.28\n0.001\n\n\nHospital Region\n\n\n\n\n\n\n\n\n    Northeast\n—\n—\n\n\n\n\n    Midwest\n-0.48\n-0.60, -0.36\n&lt;0.001\n\n\n    South\n-0.19\n-0.31, -0.08\n&lt;0.001\n\n\n    West\n-0.40\n-0.53, -0.27\n&lt;0.001\n\n\nHospital Bed Size\n\n\n\n\n\n\n\n\n    Large\n—\n—\n\n\n\n\n    Medium\n-0.61\n-0.70, -0.51\n&lt;0.001\n\n\n    Small\n-1.1\n-1.2, -0.97\n&lt;0.001\n\n\nHospital Location & Teaching Status\n\n\n\n\n\n\n\n\n    Urban, teaching\n—\n—\n\n\n\n\n    Rural\n-1.1\n-1.2, -1.0\n&lt;0.001\n\n\n    Urban, non-teaching\n-0.74\n-0.82, -0.65\n&lt;0.001\n\n\nElective Admission\n\n\n\n\n\n\n\n\n    Non-elective\n—\n—\n\n\n\n\n    Elective\n0.93\n0.82, 1.0\n&lt;0.001\n\n\nElixhauser Comorbidity Index\n0.80\n0.77, 0.83\n&lt;0.001\n\n\n\nAbbreviation: CI = Confidence Interval\n\n\n\n\n\n\n\n\n\n\nInflation-Adjusted Hospital Costs ($)\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nBeta\n95% CI\np-value\n\n\n\n\nIDA categories\n\n\n\n\n\n\n\n\n    IBD without IDA\n—\n—\n\n\n\n\n    IBD with IDA\n-74\n-437, 288\n0.7\n\n\nIBD Phenotype\n\n\n\n\n\n\n\n\n    Crohn's Disease\n—\n—\n\n\n\n\n    Ulcerative Colitis\n506\n270, 743\n&lt;0.001\n\n\nAge, years\n-49\n-58, -40\n&lt;0.001\n\n\nFemale Sex\n\n\n\n\n\n\n\n\n    Male\n—\n—\n\n\n\n\n    Female\n-1,063\n-1,298, -827\n&lt;0.001\n\n\nRace/Ethnicity\n\n\n\n\n\n\n\n\n    White\n—\n—\n\n\n\n\n    Asian or Pacific Islander\n2,950\n1,636, 4,264\n&lt;0.001\n\n\n    Black\n434\n56, 813\n0.024\n\n\n    Hispanic\n1,235\n771, 1,699\n&lt;0.001\n\n\n    Other\n1,655\n935, 2,374\n&lt;0.001\n\n\nMedian Household Income Quartile (by ZIP)\n\n\n\n\n\n\n\n\n    Q1\n—\n—\n\n\n\n\n    Q2\n689\n386, 993\n&lt;0.001\n\n\n    Q3\n1,117\n803, 1,431\n&lt;0.001\n\n\n    Q4\n2,382\n1,986, 2,778\n&lt;0.001\n\n\nPrimary Expected Payer\n\n\n\n\n\n\n\n\n    Medicare\n—\n—\n\n\n\n\n    Medicaid\n821\n352, 1,289\n&lt;0.001\n\n\n    Other\n397\n-31, 826\n0.069\n\n\n    Private\n1,023\n680, 1,366\n&lt;0.001\n\n\nHospital Region\n\n\n\n\n\n\n\n\n    Northeast\n—\n—\n\n\n\n\n    Midwest\n-2,497\n-2,998, -1,995\n&lt;0.001\n\n\n    South\n-2,465\n-2,925, -2,005\n&lt;0.001\n\n\n    West\n2,957\n2,296, 3,618\n&lt;0.001\n\n\nHospital Bed Size\n\n\n\n\n\n\n\n\n    Large\n—\n—\n\n\n\n\n    Medium\n-1,984\n-2,359, -1,608\n&lt;0.001\n\n\n    Small\n-2,920\n-3,264, -2,577\n&lt;0.001\n\n\nHospital Location & Teaching Status\n\n\n\n\n\n\n\n\n    Urban, teaching\n—\n—\n\n\n\n\n    Rural\n-1,833\n-2,246, -1,420\n&lt;0.001\n\n\n    Urban, non-teaching\n-2,375\n-2,680, -2,071\n&lt;0.001\n\n\nElective Admission\n\n\n\n\n\n\n\n\n    Non-elective\n—\n—\n\n\n\n\n    Elective\n11,009\n10,534, 11,484\n&lt;0.001\n\n\nElixhauser Comorbidity Index\n2,235\n2,128, 2,342\n&lt;0.001\n\n\n\nAbbreviation: CI = Confidence Interval"
  }
]